Co-founded by Nobel Prize winner, backed with $266M, biotech now will axe 90 jobs


The company is working in a cell therapy space attempting to treat blood cancers and solid tumors.

Previous Denver health care company scraps plan for IPO
Next Baltimore startup Delfi Diagnostics raises $225M with plans to change how lung cancer is diagnosed